Continuous processing technologies and methods should be tested with actual production processes says Tom Ransohoff from CDMO 4th Dimension Bioprocess. Continuous-mode manufacturing has been a hot topic for the drug industry for the past few years but, as yet, few companies have fully embraced the approach and even fewer have switched from fed-batch production. But the change is coming according to Tom Ransohoff, COO at recently founded CDMO 4th Dimension Bioprocess, who told delegates at the BPI East conference in…
Monday, November 9, 2020 Daily Archives
CDMO Minaris invests $64.5m to triple capacity in Europe
The cell and gene therapy CDMO will build additional facilities at its German and Japanese locations. The contract development and manufacturing organization (CDMO) specializing in cell and gene therapies announced two separate investments of $40.7 million (€34.2 million) into its Ottobrunn, Germany, site, and $23.8 million for its Yokohama, Japan, site. Both regions now come under the umbrella of Minaris Regenerative Medicine, a subsidiary of Showa Denko Materials, after a rebrand in September to unify the name of its three…
Flew vaccine? Merck teams to deliver meds by drone
Merck & Co. has partnered with Volansi to test delivering cold chain products from a North Carolina manufacturing facility to a nearby health clinic. The ‘pilot’ scheme sees Merck (known as MSD outside of North America) use Volansi’s VOLY C10 drone to deliver vaccines and medicinal products from its facility in Wilson, North Carolina to Vidant Healthplex-Wilson, a Vidant Health clinic about two miles away. “This project is starting with Merck’s vaccines against measles, mumps, rubella, chickenpox, pneumonia, and hepatitis,